Correlation Between Fusion Pharmaceuticals and Inventiva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fusion Pharmaceuticals and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fusion Pharmaceuticals and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fusion Pharmaceuticals and Inventiva Sa, you can compare the effects of market volatilities on Fusion Pharmaceuticals and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fusion Pharmaceuticals with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fusion Pharmaceuticals and Inventiva.

Diversification Opportunities for Fusion Pharmaceuticals and Inventiva

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fusion and Inventiva is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fusion Pharmaceuticals and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Fusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fusion Pharmaceuticals are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Fusion Pharmaceuticals i.e., Fusion Pharmaceuticals and Inventiva go up and down completely randomly.

Pair Corralation between Fusion Pharmaceuticals and Inventiva

If you would invest  375.00  in Fusion Pharmaceuticals on October 25, 2024 and sell it today you would earn a total of  0.00  from holding Fusion Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.56%
ValuesDaily Returns

Fusion Pharmaceuticals  vs.  Inventiva Sa

 Performance 
       Timeline  
Fusion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Fusion Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Inventiva Sa 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inventiva Sa has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Fusion Pharmaceuticals and Inventiva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fusion Pharmaceuticals and Inventiva

The main advantage of trading using opposite Fusion Pharmaceuticals and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fusion Pharmaceuticals position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.
The idea behind Fusion Pharmaceuticals and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories